search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
COAGULATION


switch detection wavelength automatically to minimise the effect of interference from samples with high intralipid concentrations.1


Unique testing capabilities The CN-Series works on the optical detection principle used by >80% of the haemostasis market in the UK. Sysmex’s refinement of this technology provides a multi-wavelength detection system using transmitted light to allow simultaneous analysis of clotting, chromogenic and immunoassays. The CN-Series incorporates a new light-emitting diode (LED) light source to reduce operator maintenance and increase system reliability. Turnaround times for clotting assays


are improved over previous-generation systems. Time interval endpoint checking improves the ‘time to result’ by two minutes per test while maintaining the unique feature of pre-sample warming prior to analysis.


Automated platelet aggregation analysis is another feature of the CN-


Sysmex Intelligent Laboratory Automation (ILA) provides beneficial workflow solutions by allowing up to three CN-Series systems to be connected via a Sysmex Track.


Series systems. This provides significant workflow and performance improvements over semi- automated analysers and manual techniques. The CN-Series further simplifies platelet aggregation by automating the dilution of agonists onboard the system. Customisable dilutions pre-set by the CN user can be created based on the stock concentration of the agonist used, which removes the need for a separate aggregometer.


Sample volume is dramatically reduced, meaning fewer samples are required from each patient. Hardware improvements over the highly successful CS-Series systems have not been forgotten either. The new highly durable piercer design offers a 35% reduction in sample dead volume, allowing further assays to be performed for specialty testing. System detergents and distilled water are now connected to the analyser, freeing spaces on the reagent table. Furthermore, an enhanced cooling system allows increased onboard stability for reagent, quality control (QC) and calibrator materials.


Calibration curves for linear MDA one-stage factor assays on the CN-Series avoids extrapolation (above), while ensuring factor activity to <1 IU/dL (below), essential for the diagnosis and management of haemophilia and factor deficiencies.


Software development Sysmex offers middleware validation through Extended-IPU (EPU) and Caresphere, the latter being a new web- based solution for monitoring quality, workload and workflow data across haemostasis, haematology and urinalysis. Innovative features include workload


prediction software, which indicates the required amounts of each reagent for the daily workload based on historical system data. Enhanced QC options allow users to specify automated regimes based on: n test count QC (eg every 100 x PT tests, 10 x D-dimer tests)


n time interval (eg every four hours…)


Clot waveform analysis is an extended interrogation of the coagulation curve generated by the optical detection system


40 DECEMBER 2020 WWW.PATHOLOGYINPRACTICE.COM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62